Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958399 · ClinicalTrials.gov registry record · NA
Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00958399: Completed NA study, sponsored by University of Minnesota.
NCT00958399 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00958399, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Research suggests dietary fiber may play a role in weight management, and fiber consumption is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These effects may be mediated by increased satiety, reduced food intake, or changes in blood levels of glucose, insulin, and gut hormones. The purpose of this study is to determine the satiety, glycemic, hormonal, and gastrointestinal responses of novel fiber supplements.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Resistant Starch
- DIETARY_SUPPLEMENT Resistant starch + soluble fiber
- DIETARY_SUPPLEMENT Fiber made from corn starch
- DIETARY_SUPPLEMENT Fiber made from corn starch + soluble fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT00958399 record still lists
NCT00958399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00958399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00958399 about?
NCT00958399 is a clinical study titled "Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers". Research suggests dietary fiber may play a role in weight management, and fiber consumption is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These effects may be mediated by increased satiety, reduced food intake, or changes in blood levels of glucose, insulin,...
What is the current status of trial NCT00958399?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00958399?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Resistant Starch (DIETARY_SUPPLEMENT), Resistant starch + soluble fiber (DIETARY_SUPPLEMENT), Fiber made from corn starch (DIETARY_SUPPLEMENT), Fiber made from corn starch + soluble fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00958399?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00958399's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia